glp-1 and birth control Women advised to pair effective contraception with 'skinny jabs' | Medical research I'm excited to dive into
Description
409.Yen F-S, et al
These landmark studies, required by regulatory authorities including the EMA and MHRA , have provided reassuring evidence about the cardiovascular safety profile of this drug class
Lean mass loss with semaglutide treatment in patients with obesity
Adolescents may experience significant pressure from parents, peers, and society to lose weight, potentially compromising their ability to make truly autonomous decisions about treatment
The SURMOUNT-1 trial demonstrated up to 22.5% body weight reduction with tirzepatide at the highest dose (15mg weekly), compared to semaglutide's 14.9% in STEP 1
